TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
GlaxoSmithKline AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,087,065
|
877,849
|
859,242 |
Financial expenses |
1,588
|
401
|
291 |
Earnings before taxes |
34,598
|
28,269
|
27,869 |
EBITDA |
34,689
|
30,613
|
30,580 |
Total assets |
348,057
|
334,704
|
366,501 |
Current assets |
340,853
|
333,508
|
362,723 |
Current liabilities |
252,904
|
244,649
|
268,805 |
Equity capital |
94,946
|
87,278
|
91,018 |
- share capital |
50,652
|
47,296
|
48,761 |
Employees (average) |
76
|
70
|
69 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
27.3%
|
26.1%
|
24.8% |
Turnover per employee |
14,303
|
12,541
|
12,453 |
Profit as a percentage of turnover |
3.2%
![]() |
3.2%
![]() |
3.2% |
Return on assets (ROA) |
10.4%
|
8.6%
|
7.7% |
Current ratio |
134.8%
|
136.3%
|
134.9% |
Return on equity (ROE) |
36.4%
|
32.4%
|
30.6% |
Change turnover |
146,927
|
44,430
|
-37,175 |
Change turnover % |
16%
|
5%
|
-4% |
Chg. No. of employees |
6
|
1
|
-4 |
Chg. No. of employees % |
9%
|
1%
|
-5% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.